EN ZH NEWS NEWARK, CA • MAY 8, 2023 AceLink Therapeutics Appoints Pedro Huertas, M.D., Ph.D., as Chief Medical Officer (BUSINESS WIRE)–AceLink Therapeutics, Inc., a clinical stage biopharmaceutical company developing the next generation of oral substrate reduction therapies (SRTs) to address significant unmet medical needs and improve the quality of life of patients with inherited …